Immunoregulatory role of CD1d in the hydrocarbon oil-induced model of lupus nephritis

Journal of Immunology

Volumn 171, Issue 4, 2003, Pages 2142-2153

  Yang, Jun Qi ^a   Singh, Avneesh K ^b   Wilson, Michael T ^b   Satoh, Minoru ^c   Stanic, Aleksandar K ^b   Park, Jang June ^b   Hong, Seokmann ^a,e   Gadola, Stephan D ^d   Mizutani, Akiei ^c   Kakumanu, Srinivasa R ^a   Reeves, Westley H ^c   Cerundolo, Vincenzo ^d   Joyce, Sebastian ^b   Van Kaer, Luc ^b   Singh, Ram Raj ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Sejong University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; HYDROCARBON; INTERLEUKIN 4; OIL; PRISTANE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN FUNCTION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE MODEL; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOREGULATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0043136663     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.4.2142     Document Type: Article

References (50)

1. + T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J. Immunol. 143:103.
2. Singh, R. R., V. Kumar, F. M. Ebling, S. Southwood, A. Sette, E.E. Sercarz, and B. H. Hahn. 1995. T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus. J. Exp. Med. 181:2017.
3. Peng, S. L., M. P. Madaio, A. C. Hayday, and J. Craft. 1996. Propagation and regulation of systemic autoimmunity by γδ T cells. J. Immunol. 157:5689.
4. Singh, R. R., B. H. Hahn, and E. E. Sercarz. 1996. Neonatal peptide exposure can prime T cells, and upon subsequent immunization induce their immune deviation: implications for antibody- vs. T cell-mediated autoimmunity. J. Exp. Med. 183:1613.
5. + T suppressor cell function in patients with active systemic lupus erythematosus. J. Immunol. 166:6452.
6. Singh, R. R., F. M. Ebling, D. A. Albuquerque, V. Saxena, V. Kumar, E. H. Giannini, T. N. Marion, F. D. Finkelman, and B. H. Hahn. 2002. Induction of autoantibody production is limited in nonautoimmune mice. J. Immunol. 169:587.
7. Fan, G., and R. R. Singh. 2002. Vaccination with minigenes encoding VH-derived MHC class I-binding epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus. J. Exp. Med. 196:731.
8. + NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 156:4035.
9. + double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum. 44:1127.
10. Oishi, Y., T. Sumida, A. Sakamoto, Y. Kita, K. Kurasawa, Y. Nawata, K. Takabayashi, H. Takahashi, S. Yoshida, M. Taniguchi, Y. Saito, and I.Iwamoto. 2001. Selective reduction and recovery of invariant Vα24JαQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus. J. Rheumatol. 28:275.
11. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 100:144.
12. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. 224Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535.
13. Porcelli, S. A., and R. L. Modlin. 1999. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17:297.
14. Gumperz, J. E., C. Roy, A. Makowska, D. Lum, M. Sugita, T. Podrebarac, Y. Koezuka, S. A. Porcelli, S. Cardell, M. B. Brenner, and S. M. Behar. 2000. Murine CD1d-restricted T cell recognition of cellular lipid. Immunity 12:211.
15. Morita, M., K. Motoki, K. Akimoto, T. Natori, T. Sakai, E. Sawa, K. Yamaji, Y. Koezuka, E. Kobayashi, and H. Fukushima. 1995. Structure-activity relationship of α-galactosylceramides against B 16-bearing mice. J. Med. Chem. 38:2176.
16. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C. R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med 192:741.
17. Karadimitris, A., S. Gadola, M. Altamirano, D. Brown, A. Woolfson, P. Klenerman, J. L. Chen, Y. Koezuka, I. A. Roberts, D. A. Price, et al. 2001. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc. Natl. Acad. Sci. USA 98:3294.
18. Stanic, A. K., A. D. De Silva, J. J. Park, V. Sriram, S. Ichikawa. Y. Hirabyashi, K. Hayakawa, L. Van Kaer, R. R. Brutkiewicz, and S. Joyce. 2003. Defective presentation of the CD1d1-restricted natural Vα14Jα18 NKT lymphocyte antigen caused by β-D-glucosylceramide synthase deficiency. Proc. Natl. Acad. Sci. USA 100:1849.
19. Hammond, K. J., and D. I. Godfrey. 2002. NKT cells: potential targets for autoimmune disease therapy? Tissue Antigens 59:353.
20. Hong, S., M. T. Wilson, I. Serizawa, L. Wu, N. Singh, O. Naidenko, T. Miura, T. Haba, D. C. Scherer, J. Wei, et al.. 2001. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7:1052.
21. Wang, B., Y. B. Geng, and C. R. Wang. 2001. CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes J. Exp. Med. 194:313.
22. Singh, R. R., V. Saxena, S. Zang, L. Li, F. D. Finkelman, D. P. Witte, and C. O. Jacob. 2003. Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J. Immunol. 170:4818.
23. Satoh, M., and W. H. Reeves. 1994. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J. Exp. Med. 180:2341.
24. Richard, H. B., M. Satoh, J. C. Jennette, B. P. Croker, H. Yoshida, and W. H. Reeves. 2001. Interferon-γ is required for lupus nephritis in mice treated with the hydrocarbon oil pristane. Kidney Int. 60:2173.
25. Mendiratta, S. K., W. D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6:469.
26. Satoh, M., H. B. Richards, V. M. Shaheen, H. Yoshida, M. Shaw, J. O. Naim, P. H. Wooley, and W. H. Reeves. 2000. Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin. Exp. Immunol. 121:399.
27. Singh, N., S. Hong, D. C. Scherer, I. Serizawa, N. Burdin, M. Kronenberg, Y. Koezuka, and L. Van Kaer. 1999. Cutting edge: activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 163:2373.
28. Gadue, P., and P. L. Stein. 2002. NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation. J. Immunol. 169:2397.
29. Martin, F., and J. F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 2:323.
30. Wither J. E., A. D. Paterson, and B. Vukusic. 2000. Genetic dissection of B cell traits in New Zealand black mice: the expanded population of B cells expressing up-regulated costimulatory molecules shows linkage to Nba2. Eur. J. Immunol. 30:356.
31. Bennett, L., A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197:711.
32. lpr mice: an example of disease regulation at the organ level. J. Immunol. 167:2985.
33. Wallace, D. J. 2002. The clinical presentation of systemic lupus erythematosus. In Dubois' Lupus Erythematosus, Vol. 6. D. J. Wallace and B. H. Hahn, eds. Lippincott Williams & Wilkins, Philadelphia, PA, p. 621.
34. Zeng, D., M. Dick, L. Cheng, M. Amano, S. Dejbakhsh-Jones, P. Huie, R. Sibley, and S. Strober. 1998. Subsets of transgenic T cells that recognize CD1 induce or prevent murine lupus: role of cytokines. J. Exp. Med. 187:525.
35. + NKT cells derived from multiple sclerosis in remission. Int. Immunol. 15:279.
36. Jacob, C. O., and H. O. McDevitt. 1988. Tumor necrosis factor-α in murine autoimmune 'lupus' nephritis. Nature 331:356.
37. Fujimura, T., S. Hirose, Y. Jiang, S. Kodera, H. Ohmuro, D. Zhang, Y. Hamano, H. Ishida, S. Furukawa, and T. Shirai. 1998. Dissection of the effects of tumor necrosis factor-α and class II gene polymorphisms within the MHC on murine systemic lupus erythematosus (SLE). Int. Immunol. 10:1467.
38. Kontoyiannis, D., and G. Kollias. 2000. Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor. Eur. J. Immunol. 30:2038.
39. Brennan, D. C., M. A. Yui, R. P. Wuthrich, and V. E. Kelley. 1989. Tumor necrosis factor and IL-1 in New Zealand Black/White mice: enhanced gene expression and acceleration of renal injury. J. Immunol. 143:3470.
40. Sonoda, K. H., M. Exley, S. Snapper, S. P. Balk, and J. Stein-Streilein. 1999. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190:1215.
41. Sonoda, K. H., and J. Stein-Streilein. 2002. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur. J. Immunol. 32:848.
42. Naumov, Y. N., K. S. Bahjat, R. Gausling, R. Abraham, M. A. Exley, Y. Koezuka, S. B. Balk, J. L. Strominger, M. Clare-Salzer, and S. B. Wilson. 2001. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 98:13838.
43. Grimaldi, C. M., D. J. Michael, and B. Diamond. 2001. Expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol. 167:1886.
44. Li, Y., H. Li, and M. Weigert. 2002. Autoreactive B cells in the marginal zone that express dual receptors. J. Exp. Med. 195:181.
45. Zeng, D., M. K. Lee, J. Tung, A. Bredolan, and S. Strober. 2000. A role of CD1 in the pathogenesis of lupus in NZB/NZW mice. J. Immunol. 164:5000.
46. 1 mice. Clin. Immunol. 94:51.
47. + CD1d-dependent precursor stage. J. Exp. Med. 195:835.
48. Gapin, L., J. L. Matsuda, C. D. Surh, and M. Kronenberg. 2001. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2:971.
49. Ikarashi, Y, R. Mikami, A. Bendelac, M. Terme, N. Chaput, M. Terada, T. Tursz, E. Angevin, F. A. Lemonnier, H. Wakasugi, and L. Zitvogel. 2001. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon γ production. J. Exp. Med. 194:1179.
50. 1 mice. Arthritis Rheum. 46:2235.